The drugs industry closed the day down 2%. Tibet Pharmaceuticals Inc ( TBET), Momenta Pharmaceuticals Inc ( MNTA), Cardium Therapeutics Inc ( CXM), and Pacific Biosciences of California Inc ( PACB) were all decliners today within the drugs industry with Teva Pharmaceutical Industries ( TEVA) being today's featured drugs loser. Teva Pharmaceutical Industries fell 42 cents (-1.1%) to $39.11 on light volume. Throughout the day, four million shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 6.6 million shares. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs; and proprietary branded pharmaceuticals in various therapeutic categories and active pharmaceutical ingredients worldwide. Teva Pharmaceutical Industries has a market cap of $34.9 billion and is part of the health care sector. The company has a P/E ratio of 8.3, below the average drugs industry P/E ratio of 11.3 and below the S&P 500 P/E ratio of 17.7. Shares are down 24.9% year to date as of the close of trading on Monday. TheStreet Ratings rates Teva as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and a generally disappointing performance in the stock itself.
- You can view the full Teva Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.